Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1Phase 1 1

Status

Completed 6Recruiting 5Terminated 4Withdrawn 2Active not recruiting 2Unknown 1

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 4Gastrointestinal 2Thoracic 1Head & Neck 1Gynecologic 1Dermatologic 1Breast 1

Conditions

Prostatic Neoplasms 25Neoplasm Metastasis 5Breast Neoplasms 5Prostatic Neoplasms, Castration-Resistant 4Pancreatic Neoplasms 3Triple Negative Breast Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Prostate Cancer Metastatic 2Metastatic Castration-resistant Prostate Cancer 2Melanoma 2Carcinoma, Renal Cell 2Bulbo-Spinal Atrophy, X-Linked 2Urinary Bladder Neoplasms 1Thrombocytosis 1Solid Tumours 1Small Cell Lung Carcinoma 1Prostate Adenocarcinoma 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Patient Preference 1Ovarian Neoplasms 1Non-Muscle Invasive Bladder Neoplasms 1Neoplasms, Squamous Cell 1NSCLC Harboring NRG1 Fusion 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Multiple Myeloma 1Metastatic Castration Resistant Prostate Cancer 1Metastatic Castrate-Resistant Prostate Cancer 1

Interventions

enzalutamide 4abiraterone 2Docetaxel 2tasquinimod 1sabizabulin 1olaparib 1ipatasertib 1darolutamide 1atezolizumab 1Nivolumab 1Abiraterone Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Terminated × Prostatic Neoplasms, Castration-Resistant × enzalutamide × Clear all
NCT05551117 2026-02-09

Tamarack

MacroGenics

Phase 2 Terminated
192 enrolled 20 charts
DermatologicGastrointestinalGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Anus Neoplasms, Carcinoma, Non-Small-Cell Lung, Melanoma, Carcinoma, Small Cell, Small Cell Lung Carcinoma, Prostatic Neoplasms, Castration-Resistant

NCT05252390 2025-11-06

NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors

Nuvation Bio Inc.

Phase 1 Terminated
82 enrolled
BreastGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant, Triple Negative Breast Neoplasms

NCT04844749 2024-02-05

VERACITY

Veru Inc.

Phase 3 Terminated
105 enrolled
Genitourinary

Prostatic Neoplasms, Castration-Resistant

NCT04157088 2023-08-04

DaroAcT

Bayer

Phase 2 Terminated
30 enrolled 25 charts
Genitourinary

Prostatic Neoplasms, Castration-Resistant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡